Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Oriental Aromatics Limited (OAL.NS)
Mumbai, IN
Oriental Aromatics Limited, established in Mumbai, India, in 1955, is a leading manufacturer and supplier of terpene chemicals, camphor, and various specialty aroma ingredients. Operating as Camphor & Allied Products Limited until its rebranding in February 2018, the company provides specialized aroma chemicals critical for the flavor, fragrance, and essential oil sectors. Its offerings also include synthetic camphor for medicinal and religious uses, alongside specific products such as terpineol, pine oils, astromusk, isobornyl acetate, and terpene resins. Additionally, Oriental Aromatics develops fragrances for a broad spectrum of consumer goods, including soaps, shampoos, hair oils, detergents, incense sticks, cosmetics, toiletries, household cleaners, and air fresheners. Its flavor solutions serve diverse industries such as instant food, beverages, dairy, confectionery, oral hygiene, sweets, meat, snacks, healthcare, and bakeries. Beyond its domestic operations, the company boasts a robust global footprint, exporting its products to numerous countries across North America, South America, Europe, Africa, and Asia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.06% | +2.67% | -0.82% | +12.60% | -5.02% | +6.60% | -25.40% | -15.94% | -60.95% | +58.76% | +58.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+11.7% ★ Q1'26: +11.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-90.4% Q1'26: +181.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-5.5% Q1'26: -12.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.6% Q1'26: +4.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.1% Q1'26: +2.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.2% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.92× Q1'26: 5.17× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.17B
est: 2.11B (+2.9%)
|
5.04B
est: 3.79B (+32.9%)
|
7.53B
est: 4.08B (+84.7%)
|
7.60B
est: 7.81B (-2.7%)
|
7.09B
est: 8.67B (-18.2%)
|
8.66B
est: 21.12B (-59.0%)
|
8.49B
est: 51.45B (-83.5%)
|
3.79B
3.79B – 3.79B
-92.6% YoY
|
3.79B
3.79B – 3.79B
+0.0% YoY
|
4.08B
4.08B – 4.08B
+7.5% YoY
|
7.81B
7.81B – 7.81B
+91.5% YoY
|
8.67B
8.67B – 8.67B
+11.0% YoY
|
| EBITDA |
148.56M
est: 237.90M (-37.6%)
|
655.99M
est: 428.52M (+53.1%)
|
1.14B
est: 460.65M (+147.4%)
|
1.29B
est: 881.93M (+46.0%)
|
1.56B
est: 978.94M (+59.5%)
|
969.36M
est: 2.97B (-67.4%)
|
543.09M
est: 5.84B (-90.7%)
|
428.52M
428.52M – 428.52M
-92.7% YoY
|
428.52M
428.52M – 428.52M
+0.0% YoY
|
460.65M
460.65M – 460.65M
+7.5% YoY
|
881.93M
881.93M – 881.93M
+91.5% YoY
|
978.94M
978.94M – 978.94M
+11.0% YoY
|
| EBIT |
90.54M
est: 188.84M (-52.1%)
|
500.87M
est: 340.14M (+47.3%)
|
961.33M
est: 365.66M (+162.9%)
|
1.10B
est: 700.05M (+56.7%)
|
1.39B
est: 777.06M (+78.5%)
|
757.27M
est: 2.91B (-74.0%)
|
348.81M
est: 4.64B (-92.5%)
|
340.14M
340.14M – 340.14M
-92.7% YoY
|
340.14M
340.14M – 340.14M
+0.0% YoY
|
365.66M
365.66M – 365.66M
+7.5% YoY
|
700.05M
700.05M – 700.05M
+91.5% YoY
|
777.06M
777.06M – 777.06M
+11.0% YoY
|
| Net Income |
76.51M
est: 214.41M (-64.3%)
|
249.82M
est: 445.64M (-43.9%)
|
571.43M
est: 495.68M (+15.3%)
|
861.89M
est: 549.97M (+56.7%)
|
1.02B
est: 937.78M (+8.7%)
|
533.02M
est: 2.33B (-77.1%)
|
197.43M
est: 5.69B (-96.5%)
|
445.64M
445.64M – 445.64M
-92.2% YoY
|
445.64M
445.64M – 445.64M
+0.0% YoY
|
495.68M
495.68M – 495.68M
+11.2% YoY
|
812.09M
812.09M – 812.09M
+63.8% YoY
|
937.78M
937.78M – 937.78M
+15.5% YoY
|
| SGA |
77.79M
est: 133.98M (-41.9%)
|
198.60M
est: 241.34M (-17.7%)
|
282.02M
est: 259.44M (+8.7%)
|
323.11M
est: 496.71M (-34.9%)
|
401.92M
est: 551.34M (-27.1%)
|
325.37M
est: 1.09B (-70.1%)
|
573.80M
est: 3.29B (-82.6%)
|
241.34M
241.34M – 241.34M
-92.7% YoY
|
241.34M
241.34M – 241.34M
+0.0% YoY
|
259.44M
259.44M – 259.44M
+7.5% YoY
|
496.71M
496.71M – 496.71M
+91.5% YoY
|
551.34M
551.34M – 551.34M
+11.0% YoY
|
| EPS |
3.73
est: 6.36 (-41.4%)
|
7.42
est: 13.23 (-43.9%)
|
16.98
est: 14.71 (+15.4%)
|
25.61
est: 24.10 (+6.3%)
|
30.29
est: 27.83 (+8.8%)
|
15.84
est: 69.30 (-77.1%)
|
5.87
est: 172.56 (-96.6%)
|
13.23
13.23 – 13.23
-92.3% YoY
|
13.23
13.23 – 13.23
+0.0% YoY
|
14.71
14.71 – 14.71
+11.2% YoY
|
24.10
24.10 – 24.10
+63.8% YoY
|
27.83
27.83 – 27.83
+15.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dharmil Anil Bodani | Chairman & MD | 47M | male |
| Shyamal Anil Bodani | Executive Director | 38M | male |
| Satish Kumar Ray | Executive Director of Operations & Whole Time Director | 4M | male |
| Anita Parag Satoskar | Chief Technology Officer | — | female |
| Parag K. Satoskar | Chief Executive Officer | — | male |
| Kiranpreet Kaur Gill | Company Secretary & Compliance Officer | — | female |
| Dhirendra Bacchav | Deputy General Manager of HR | — | male |
| Girish Khandelwal | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OAL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
